Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Anthony P Heaney"'
Publikováno v:
International Journal of General Medicine, Vol 2009, Iss default, Pp 209-217 (2009)
Stephanie Smooke Praw1, Anthony P Heaney1,21Department of Medicine, 2Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Cushing's disease, due to pituitary adrenocorticotropic hormone (ACTH) hypersecret
Externí odkaz:
https://doaj.org/article/460a8f77a04246b99a3759093a762c2b
Autor:
Mônica Gadelha, Peter J. Snyder, Przemysław Witek, Marie Bex, Zhanna Belaya, Adina F. Turcu, Richard A. Feelders, Anthony P. Heaney, Michaela Paul, Alberto M. Pedroncelli, Richard J. Auchus
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveTo evaluate the long-term efficacy and safety of osilodrostat in patients with Cushing’s disease.MethodsThe multicenter, 48-week, Phase III LINC 4 clinical trial had an optional extension period that was initially intended to continue to w
Externí odkaz:
https://doaj.org/article/372be9dc61a0418b932676d46aae10b2
Autor:
Yingying Yang, Lilit Babayan, Argishty Mirzakhanian, Nvard Sisliyan, Dongyun Zhang, Carolina Hurtado, Abdul Zahid, Marvin Bergsneider, Won Kim, Marilene B. Wang, Anthony P. Heaney
Publikováno v:
Heliyon, Vol 9, Iss 1, Pp e12678- (2023)
Background: FK506 binding protein 51 (FKBP5) is a co-chaperone regulator of the glucocorticoid receptor (GR). Recent studies have reported increased FKBP5 mRNA in the circulation from patients with Cushing disease (CD) which returned to comparable le
Externí odkaz:
https://doaj.org/article/0dbd2adbafdd481d9beb37cd8707c55c
Autor:
Justin P. McCormick, Matthew Sun, Iram Shafqat, Anthony P. Heaney, Marvin Bergsneider, Marilene B. Wang
Publikováno v:
Interdisciplinary Neurosurgery, Vol 27, Iss , Pp 101371- (2022)
Introduction: The association between Cushing syndrome and a hypercoagulable state has been demonstrated in the literature. A standard venous thromboembolism (VTE) prophylaxis regimen has yet to be established for patients undergoing surgery for Cush
Externí odkaz:
https://doaj.org/article/69d08fb59d4e4604abb8607fbc234f1e
Autor:
Na Sun, Yi-Te Lee, Ryan Y. Zhang, Rueihung Kao, Pai-Chi Teng, Yingying Yang, Peng Yang, Jasmine J. Wang, Matthew Smalley, Pin-Jung Chen, Minhyung Kim, Shih-Jie Chou, Lirong Bao, Jing Wang, Xinyue Zhang, Dongping Qi, Juvelyn Palomique, Nicolas Nissen, Steven-Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Daniela Markovic, David Elashoff, Hsiao-hua Yu, Huiying Li, Anthony P. Heaney, Edwin Posadas, Sungyong You, Ju Dong Yang, Renjun Pei, Vatche G. Agopian, Hsian-Rong Tseng, Yazhen Zhu
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Extracellular vesicles (EVs) are present in circulation at relatively early stages of disease, providing potential opportunities for early cancer diagnosis. Here, the authors report a covalent chemistry-based hepatocellular carcinoma (HCC)-specific E
Externí odkaz:
https://doaj.org/article/7cae50dc76a9464fb0cb00c27a2f9b1f
Autor:
Dongyun Zhang, William H. Yong, Masoud Movassaghi, Fausto J. Rodriguez, Issac Yang, Paul McKeever, Jiang Qian, Jian Yi Li, Qinwen Mao, Kathy L. Newell, Richard M. Green, Cynthia T. Welsh, Anthony P. Heaney
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2842 (2022)
Neurocytomas are rare low-grade brain tumors predominantly affecting young adults, but their cellular origin and molecular pathogenesis is largely unknown. We previously reported a sellar neurocytoma that secreted excess arginine vasopressin causing
Externí odkaz:
https://doaj.org/article/1f7cecf9d5f842ad94a57f692b31c655
Autor:
Dongyun Zhang, Willy Hugo, Peter Redublo, Hui Miao, Marvin Bergsneider, Marilene B. Wang, Won Kim, William H. Yong, Anthony P. Heaney
Publikováno v:
EBioMedicine, Vol 66, Iss , Pp 103294- (2021)
Background: Cushing disease (CD), although rare, is a life-threatening disorder caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma, which leads to excess adrenal-derived cortisol. Efficacious and safe medical therapies that c
Externí odkaz:
https://doaj.org/article/2601596e7f584ac4b65e0bb080bf7b79
Autor:
Yingying Yang, Joel R. Hecht, Sandy Ting Liu, Melissa J. Cohen, Steven D. Hart, Hanlin L. Wang, Anthony P. Heaney
Publikováno v:
AACE Clinical Case Reports, Vol 6, Iss 5, Pp e239-e242 (2020)
ABSTRACT: Objective: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 diffe
Externí odkaz:
https://doaj.org/article/c5fcc872bf2f48bda64b3a1257268629
Autor:
Maria Fleseriu, Richard J Auchus, Yona Greenman, Sabina Zacharieva, Eliza B Geer, Roberto Salvatori, Rosario Pivonello, Ulla Feldt-Rasmussen, Laurence Kennedy, Michael Buchfelder, Beverly M K Biller, Fredric Cohen, Anthony P Heaney
Publikováno v:
Fleseriu, M, Auchus, R J, Greenman, Y, Zacharieva, S, Geer, E B, Salvatori, R, Pivonello, R, Feldt-Rasmussen, U, Kennedy, L, Buchfelder, M, Biller, B M K, Cohen, F & Heaney, A P 2022, ' Levoketoconazole treatment in endogenous Cushing’s syndrome : extended evaluation of clinical, biochemical, and radiologic outcomes ', European Journal of Endocrinology, vol. 187, no. 6, pp. 859-871 . https://doi.org/10.1530/EJE-22-0506
Objective This extended evaluation (EE) of the SONICS study assessed the effects of levoketoconazole for an additional 6 months following open-label, 6-month maintenance treatment in endogenous Cushing's syndrome. Design/Methods SONICS included dose-
Autor:
Ning-Ai Liu, Anat Ben-Shlomo, John D Carmichael, Christina Wang, Ronald S Swerdloff, Anthony P Heaney, Garni Barkhoudarian, Daniel Kelly, Mazen Noureddin, Lin Lu, Manish Desai, Yana Stolyarov, Kevin Yuen, Adam N Mamelak, James Mirocha, Mourad Tighiouart, Shlomo Melmed
Publikováno v:
J Clin Endocrinol Metab
Context Preclinical studies show seliciclib (R-roscovitine) suppresses neoplastic corticotroph proliferation and pituitary adrenocorticotrophic hormone (ACTH) production. Objective To evaluate seliciclib as an effective pituitary-targeting treatment